The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM

Kent S. Boles, Winfried Barchet, Tom Diacovo, Marina Cella, Marco Colonna

Research output: Contribution to journalArticle

119 Scopus citations

Abstract

The tumor suppressor in lung cancer-1 (TSLC1) gene is frequently silenced in human lung carcinomas, and its expression suppresses tumorigenesis in nude mice. TSLC1 encodes a cell-surface protein called Necl-2 that belongs to the Nectin and Nectin-like (Necl) family of molecules. Necl-2 mediates epithelial cell junctions by homotypic contacts and/or heterotypic interactions with other Nectins and Necls. Thus, it inhibits tumorigenesis by ensuring that epithelial cells grow in organized layers. Here, we demonstrate that natural killer (NK) cells and CD8+ T cells recognize Necl-2 through a receptor known as class I-restricted T-cell-associated molecule (CRTAM), which is expressed only on activated cells. CRTAM-Necl-2 interactions promote cytotoxicity of NK cells and interferon γ (IFN-γ) secretion of CD8+ T cells in vitro as well as NK cell-mediated rejection of tumors expressing Necl-2 in vivo. These results provide evidence for an additional mechanism of tumor suppression mediated by TSLC1 that involves cytotoxic lymphocytes. Furthermore, they reveal Necl-2 as one of the molecular targets that allows the immunosurveillance network to distinguish tumor cells from normal cells.

Original languageEnglish
Pages (from-to)779-786
Number of pages8
JournalBlood
Volume106
Issue number3
DOIs
StatePublished - Aug 1 2005

Fingerprint Dive into the research topics of 'The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8<sup>+</sup> T-cell responses through the cell-surface receptor CRTAM'. Together they form a unique fingerprint.

  • Cite this